KEGG   DRUG: Tixentamig
Entry
D13369                      Drug                                   
Name
Tixentamig (USAN/INN)
Formula
C5589H8635N1521O1732S40
Exact mass
126051.3197
Mol weight
126129.19
Sequence
(A chain)
EVQLVESGGG LVQPGGSLRL SCAASGFTFS SYWMHWVRQV PGKGLVWVSR ISSDASRTIY
ADSVKGRFTI SRDNAKNTLY LQMNSLRAED TAVYYCARGE DHDILTGYPI RGQGTTVTVS
SGGGGSGGGG SGGGGSEVQL VESGGGLVQP GGSLRLSCAA SGFTFSSYWM HWVRQVPGKG
LVWVSRISSD ASRTIYADSV KGRFTISRDN AKNTLYLQMN SLRAEDTAVY YCARGEDHDI
LTGYPIRGQG TTVTVSSASE PKSSDKTHTC PPCPAPEAAG APSVFLFPPK PKDTLMISRT
PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY NSTYRVVSVL TVLHQDWLNG
KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVCTLPPSRE EMTKNQVSLS CAVKGFYPSD
IAVEWESNGQ PENNYKTTPP VLDSDGSFFL VSKLTVDKSR WQQGNVFSCS VMHEALHNHY
TQKSLSLSPG K
(B chain)
EVQLVESGGG LVQPGGSLKL SCAASGFTFS TYAMNWVRQA SGKGLEWVGR IRSKYNNYAT
YYADSVKDRF TISRDDSKNT AYLQMNSLKT EDTAVYYCTR HGNFGNSYVS WFAYWGQGTL
VTVSSASTKG PSVFPLAPSS KSTSGGTAAL GCLVKDYFPE PVTVSWNSGA LTSGVHTFPA
VLQSSGLYSL SSVVTVPSSS LGTQTYICNV NHKPSNTKVD KKVEPKSCDK THTCPPCPAP
EAAGAPSVFL FPPKPKDTLM ISRTPEVTCV VVDVSHEDPE VKFNWYVDGV EVHNAKTKPR
EEQYNSTYRV VSVLTVLHQD WLNGKEYKCK VSNKALPAPI EKTISKAKGQ PREPQVYTLP
PCREEMTKNQ VSLWCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSKLTV
DKSRWQQGNV FSCSVMHEAL HNHYTQKSLS LSPGK
(C chain)
QAVVTQEPSL TVSPGGTVTL TCRSSTGAVT TSNYANWVQQ KPGQAPRGLI GGTNKRAPWT
PARFSGSLLG DKAALTLLGA QPEDEAEYFC ALWYSNLWVF GGGTKLTVLG QPKAAPSVTL
FPPSSEELQA NKATLVCLIS DFYPGAVTVA WKADSSPVKA GVETTTPSKQ SNNKYAASSY
LSLTPEQWKS HRSYSCQVTH EGSTVEKTVA PTECS
(Disulfide bridge: A22-A96, A158-A232, A270-B234, A273-B237, A305-A365, A393-B362, A411-A469, B22-B98, B152-B208, B228-C214, B269-B329, B375-B433, C22-C90, C137-C196)
  Type
Peptide
Efficacy
Antineoplastic
  Type
Bispecific antibody
Comment
Treatment of advanced and metastatic solid tumors
Target
CLDN18 [HSA:51208] [KO:K06087]
CD3E [HSA:916] [KO:K06451]
  Pathway
hsa04382  Cornified envelope formation
hsa04514  Cell adhesion molecule (CAM) interaction
hsa04530  Tight junction
hsa04640  Hematopoietic cell lineage
hsa04658  Th1 and Th2 cell differentiation
hsa04659  Th17 cell differentiation
hsa04660  T cell receptor signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD3E
     D13369  Tixentamig (USAN/INN)
   Other
    CLDN18
     D13369  Tixentamig (USAN/INN)
Other DBs
CAS: 2969220-04-8
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system